MediPal Holdings Corporation Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017; Announces Dividend for the Six Months Ended September 30, 2016; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2017
October 30, 2016
Share
MediPal Holdings Corporation announced consolidated earnings results for the six months ended September 30, 2016. For the six months, the company reported net sales of ¥1,530,406 million against ¥1,485,725 million a year ago. Operating income was ¥20,836 million against ¥18,441 million a year ago. Ordinary income was ¥26,908 million against ¥24,384 million a year ago. Income before income taxes and non-controlling interests was ¥26,775 million against ¥23,739 million a year ago. Net income attributable to owners of the parent was ¥14,066 million or ¥62.12 per share against ¥12,636 million or ¥55.80 per share a year ago. Net cash provided by operating activities was ¥7,603 million against net cash used in operating activities of ¥23,947 million a year ago. Payments for purchase of property and equipment were ¥18,239 million against ¥18,125 million a year ago.
The company provided earnings guidance for the fiscal year ending March 31, 2017. For the year, the company expects net sales of ¥3,090,000 million, operating income of ¥40,000 million, ordinary income of ¥53,500 million and net income attributable to owners of the parent of ¥30,500 million or ¥134.69 per share.
The company announced dividend for the six months ended September 30, 2016. For the six months, the company announced dividend of ¥15.00 per share against ¥13.00 per share a year ago.
The company provided dividend guidance for the fiscal year ending March 31, 2017. For the year, the company expects dividend of ¥15.00 per share against ¥15.00 per share a year ago.
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
MediPal Holdings Corporation Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017; Announces Dividend for the Six Months Ended September 30, 2016; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2017
MEDIPAL HOLDINGS CORPORATION 
